Cytokinetics, Incorporated (CYTK) earnings
CYTK earnings moved a median of -2.24% by the close. Quarterly and annual CYTK reports and results, each read against the price at its own news timestamp. Back to the CYTK overview →
15 measured CYTK earnings events.
Where these CYTK earnings landedvs 15 measured CYTK earnings reactions
| Middle 50% of CYTK earnings reactions | -4.85% to +0.70% |
|---|---|
| Median reaction (to close) | -2.24% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 CYTK earnings events with a measured close landed between -4.85% and +0.70%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -3.47% | -5.50% | |
| Form 10-Q CYTOKINETICS INC For: Jun 30 | SEC filing · Form 10-Q | -3.47% | -5.50% | |
| Cytokinetics to Announce Second Quarter Results on August 6, 2026 | Press release | -0.41% | -2.24% | |
| Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -1.45% | -4.05% | |
| Form 10-Q CYTOKINETICS INC For: Mar 31 | SEC filing · Form 10-Q | -1.45% | -4.05% | |
| Cytokinetics to Announce First Quarter Results on May 5, 2026 | Press release | -1.01% | -0.27% | |
| Form 10-K CYTOKINETICS INC For: Dec 31 | SEC filing · Form 10-K | +1.13% | +0.23% | |
| Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update | Press release | +1.54% | -7.68% | |
| Cytokinetics to Announce Fourth Quarter Results on February 24, 2026 | Press release | +0.38% | +1.18% | |
| Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.51% | +2.46% | |
| Form 10-Q CYTOKINETICS INC For: Sep 30 | SEC filing · Form 10-Q | +1.51% | +2.46% | |
| Cytokinetics to Announce Third Quarter Results on November 5, 2025 | Press release | -0.01% | +3.62% | |
| Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +1.72% | -4.85% | |
| Form 10-Q CYTOKINETICS INC For: Jun 30 | SEC filing · Form 10-Q | +1.72% | -4.85% | |
| Cytokinetics to Announce Second Quarter Results On August 7, 2025 | Press release | -0.91% | -0.67% |
Keep exploring
More CYTK: analyst actions → · SEC filings → · CYTK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | 1,806 | -0.20% | 45% |
| Spectrum Pharmaceuticals, Inc. (SPPI) | 1,780 | 0.00% | 48% |
| MYLAN NV ORDINARY SHARES (MYL) | 1,701 | -0.13% | 44% |
| Inspire Medical Systems, Inc. (INSP) | 1,692 | +0.06% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.